These include markers of neuroinflammation, that is YKL-40, cystatin C and osteopontin; total apoE, the best recognised genetic risk factors for AD; and MDH, a key enzyme in brain glucose metabolism. This evidence concerns the gene SPP1 and Alzheimer disease.